New hope for early arthritis: two drugs better than one?
NCT ID NCT04108468
Summary
This study tested if a combination of two drugs, golimumab and methotrexate, is better at controlling disease activity in people with very early psoriatic arthritis than methotrexate alone. It involved 84 adults who had not yet tried standard arthritis medications. The goal was to see if starting with stronger treatment early leads to better long-term control of joint pain, swelling, and skin symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, LS7 4SA, United Kingdom
Conditions
Explore the condition pages connected to this study.